Teijin to distribute Exogen system in Japan:
This article was originally published in Clinica
Executive Summary
Teijin is to begin distribution of Exogen's Sonic Accelerated Fracture Healing System (SAFHS) in Japan in June. The low intensity ultrasound device is approved in Japan for the healing of delayed and non-union bone fractures and Teijin has now received reimbursement approval from the Japanese Health and Welfare Ministry. The company, which has headquarters in Osaka and Tokyo, has paid a $400,000 milestone payment to Exogen. Piscataway, New Jersey-based Exogen's ultrasound and mechanical stress technologies are based on the principle that bone growth is stimulated by mechanical force.